CN120659607A - 含有麦角硫因的肌肉萎缩抑制用组合物及Src酪氨酸激酶阻碍用组合物 - Google Patents

含有麦角硫因的肌肉萎缩抑制用组合物及Src酪氨酸激酶阻碍用组合物

Info

Publication number
CN120659607A
CN120659607A CN202480011751.5A CN202480011751A CN120659607A CN 120659607 A CN120659607 A CN 120659607A CN 202480011751 A CN202480011751 A CN 202480011751A CN 120659607 A CN120659607 A CN 120659607A
Authority
CN
China
Prior art keywords
ergothioneine
composition
muscle
salt
inhibiting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202480011751.5A
Other languages
English (en)
Chinese (zh)
Inventor
胜部谅
中村友美
铃木寿荣
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suntory Holdings Ltd
Original Assignee
Suntory Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Holdings Ltd filed Critical Suntory Holdings Ltd
Publication of CN120659607A publication Critical patent/CN120659607A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN202480011751.5A 2023-02-16 2024-02-13 含有麦角硫因的肌肉萎缩抑制用组合物及Src酪氨酸激酶阻碍用组合物 Pending CN120659607A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2023-022661 2023-02-16
JP2023022661 2023-02-16
PCT/JP2024/004718 WO2024172003A1 (ja) 2023-02-16 2024-02-13 エルゴチオネインを含有する筋萎縮抑制用組成物及びＳｒｃチロシンキナーゼ阻害用組成物

Publications (1)

Publication Number Publication Date
CN120659607A true CN120659607A (zh) 2025-09-16

Family

ID=92420194

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202480011751.5A Pending CN120659607A (zh) 2023-02-16 2024-02-13 含有麦角硫因的肌肉萎缩抑制用组合物及Src酪氨酸激酶阻碍用组合物

Country Status (4)

Country Link
JP (1) JPWO2024172003A1 (https=)
CN (1) CN120659607A (https=)
TW (1) TW202448445A (https=)
WO (1) WO2024172003A1 (https=)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7759724B2 (ja) * 2018-06-29 2025-10-24 長瀬産業株式会社 エルゴチオネイン、アスコルビン酸２－グルコシド、アスコルビン酸、およびそれらの組み合わせの筋分化促進作用
JP7796118B2 (ja) * 2021-04-26 2026-01-08 サントリーホールディングス株式会社 白血球及び／又は好塩基球増加用組成物
WO2024038821A1 (ja) * 2022-08-17 2024-02-22 サントリーホールディングス株式会社 フレイル予防又は改善用組成物、及び、加齢に伴う身体活動能力低下を抑制又は改善するための組成物

Also Published As

Publication number Publication date
WO2024172003A1 (ja) 2024-08-22
JPWO2024172003A1 (https=) 2024-08-22
TW202448445A (zh) 2024-12-16

Similar Documents

Publication Publication Date Title
CN117241796A (zh) 肾功能的降低抑制或改善用组合物
CN117255683A (zh) 免疫细胞的代谢促进用组合物
CN117202904A (zh) 红血球及/或血红蛋白增加用组合物
CN119604289A (zh) 预防或改善衰弱用组合物，以及用于抑制或改善伴随年龄增长的身体活动能力下降的组合物
JP7796118B2 (ja) 白血球及び／又は好塩基球増加用組成物
CN120659607A (zh) 含有麦角硫因的肌肉萎缩抑制用组合物及Src酪氨酸激酶阻碍用组合物
CN118251219A (zh) 组胺n-甲基转移酶阻碍用组合物
CN118139535A (zh) 含有芝麻素类及麦角硫因或其盐的组合物
CN117241680A (zh) 脂肪分解促进用组合物
TW202415371A (zh) 經口組成物，及抑制來自麥角硫因或其鹽的苦味之方法
CN120640988A (zh) 含有麦角硫因的血管扩张用组合物
CN118414094A (zh) 口服组合物以及抑制来自麦角硫因的苦味的方法
CN121001582A (zh) 含有麦角硫因或其盐的用于预防、减轻或改善中暑或脱水症的组合物及用于调节细胞内外水分的组合物
AU2023318410A1 (en) Oral composition, and method for suppressing bitterness derived from ergothioneine or salt thereof and odor derived from milk-derived ceramide-containing material
HK40113453A (zh) 口服组合物以及抑制来自麦角硫因的苦味的方法
KR20250037719A (ko) 경구 조성물, 및 에르고티오네인에 유래하는 고미 및 글루코사민류 화합물에 유래하는 이미를 억제하는 방법
TW202342008A (zh) 經口組成物，及，抑制源自麥角硫因之苦味及源自穀類之油或γ－穀維素之臭味之方法
HK40124129A (zh) 预防或改善衰弱用组合物，以及用於抑制或改善伴随年龄增长的身体活动能力下降的组合物
HK40103317A (zh) 肾功能的降低抑制或改善用组合物
TW202342005A (zh) 經口組成物，及，抑制源自麥角硫因或其鹽之苦味及源自二十碳五烯酸類之臭味之方法

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40129887

Country of ref document: HK